Neurocrine Biosciences (0K6R.L) Stock Price
$142.1 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
8 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Neurocrine Biosciences, AI stock picks, stock alerts and much more.
0K6R.L AI Stock Analysis
Financial Performance
Neurocrine Biosciences' financial performance shows mixed results. The company reported a revenue of $572.6M in the last quarter, which is down by -8.8% from the previous quarter and -3% year over year. Gross profit was $563.4M, also showing a decrease of -8.9% from the previous quarter and -1.9% YoY. This suggests that Neurocrine Biosciences has been experiencing some challenges with generating profits.
The operating income profit was significantly down by -83.4% QoQ and -84% YoY, standing at $23.6M for the last quarter, indicating difficulties in managing operational costs or lower sales volume.
The EBITDA ratio stood at 0.04 last quarter, suggesting low profitability.
Stock Price
The stock price is currently trading at $145, up by 9% in the last month and by 19.7% YoY, which indicates positive investor sentiment towards Neurocrine Biosciences despite its financial performance challenges.
The RSI value stands at 70.97, potentially signaling that the stock may be overbought and could face a pullback soon as it's close to being considered 'overbought'. The stock's 200-day moving average is $114.15 indicating an upward trend in its price movement.
Alternative Data Signals
Neurocrine Biosciences' web traffic has increased significantly by around 46%, attracting an estimated 38210 visitors per month which might suggest increasing interest or engagement with their products or services.
The number of job openings has increased slightly by 9.6% MoM but decreased -8% YoY, indicating some level of uncertainty in their hiring plans.
75% of employees report a positive business outlook, which is down by -8.5% MoM and -15.7% YoY, suggesting possible internal challenges or concerns about the company's future performance.
The company's social media following has been growing rapidly with Twitter followers up by 22.8% and Facebook followers up by 166.2%, which could suggest increasing brand awareness and engagement.
Conclusion
Overall, while Neurocrine Biosciences shows promising trends in stock price, web traffic, job openings and social media engagement, there are serious concerns regarding its financial performance and employee sentiment towards the company's business outlook. Therefore, the analysis appears to be neutral on Neurocrine Biosciences' stock.
Note: This AI Stock Analysis is based on data as of September 06. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Neurocrine Biosciences (0K6R.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Neurocrine Biosciences (0K6R.L), currently trading at $142.1, will... Sign up to access price prediction.
About 0K6R.L
-
Neurocrine Biosciences, Inc.
-
Symbol
0K6R.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
14.1B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
 |
Thermo Fisher Scientific Inc. 0R0H.L |
$483.5 1.3% |
6 |
News
0K6R.L Alternative Data
Web Traffic
Neurocrine Biosciences receives an estimated 33666 monthly visitors to neurocrine.com, which is down by -11.9% over the last month.
-
Web Traffic
33666
-
Change from Previous Month
11.9%
-
3 Month Change
81%
-
YoY Change
81%
Twitter Followers
Neurocrine Biosciences has 798 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.4% over the last month.
-
Twitter Followers
798
-
Daily Change
0%
-
1 Month Change
2.4%
-
3 Month Change
6%
-
YoY Change
6%
Facebook Engagement
Neurocrine Biosciences has engaged 59 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
59
-
Daily Change
31.1%
-
1 Month Change
321.4%
-
3 Month Change
168.2%
-
YoY Change
168.2%
Job Postings
Neurocrine Biosciences currenly has an estimated 81 open job postings, up by 15.7% over the last month.
-
Job Postings
81
-
Daily Change
1.2%
-
1 Month Change
15.7%
-
3 Month Change
1.2%
-
YoY Change
1.2%
Reddit Mentions
Neurocrine Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
78,213 are following Neurocrine Biosciences on LinkedIn, up by 2.5% over the last month.
-
LinkedIn Followers
78213
-
Daily Change
2.5%
-
1 Month Change
2.5%
-
3 Month Change
6.9%
-
YoY Change
6.9%
Business Outlook
According to employee reviews, the business outlook among employees at Neurocrine Biosciences is 75 out of 100 (bullish), down by -8.5% over the last month.
-
Business Outlook
75
-
Change from Previous Month
8.5%
-
3 Month Change
7.4%
-
YoY Change
7.4%
LinkedIn Employees
According to LinkedIn, Neurocrine Biosciences has 1,984 employees, up by 1.3% over the last month.
-
LinkedIn Employees
1984
-
Daily Change
1.3%
-
1 Month Change
1.3%
-
3 Month Change
4.6%
-
YoY Change
4.6%
News Mentions
Neurocrine Biosciences was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0K6R.L Financials
0K6R.L Key Metrics
-
Total Revenue
$572.6M
-
Net Income
$7.9M
-
Earnings per Share
$0.08
-
Free cash flow
$54.1M
-
EBITDA
$23.6M
-
EBITDA Ratio
0.0412155
-
Total Assets
$3.7B
0K6R.L 2-year Revenue & Income
0K6R.L 2-year Free Cash Flow
0K6R.L Technicals
0K6R.L SMA
0K6R.L RSI
FAQ
What's the current price of Neurocrine Biosciences (0K6R.L) Stock?
The price of an Neurocrine Biosciences (0K6R.L) share is $142.1.
What's the market cap of Neurocrine Biosciences?
The current market cap of Neurocrine Biosciences is 14.1B.
What are some stocks similar to Neurocrine Biosciences (0K6R.L) that investors often compare it to?
Neurocrine Biosciences (0K6R.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Esperion Therapeutics and Thermo Fisher Scientific Inc..
What is the forecast for Neurocrine Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Neurocrine Biosciences' stock price to be around $150.8 in 2026. Starting from the current price of $142.1, this represents a 6.1% change in price, indicating a bullish outlook for the stock.
How to buy Neurocrine Biosciences (0K6R.L) Stock?
Neurocrine Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Neurocrine Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.